Milestone payments can be tricky business for publicly listed biotechs. One one hand, the cash creates a margin of safety for investors. On the other … [Read more...] about Signs of Life at Nuvo Research?
Content brought to you by:
The Cantech Letter Life Sciences section is brought to you by Relay Medical Corp. (CSNX:RELA). Relay is in the business of commercializing innovative technologies, protected by issued and pending patents, in the medical diagnostics and research field with an emphasis on In Vitro Diagnostics (IVD) and Point of Care Testing (POCT). Click on the logo for more info...
Since April 2009, when Vancouver's Cardiome (TSX:COM) signed a deal with US pharmaceutical giant Merck, it's been all systems go. That was until … [Read more...] about Bittersweet? Cardiome BC’s fastest growing company
Four years ago, SXC Health was lost in the shuffle -a mid sized healthcare IT provider from Milton, Ontario with just over $80 million in revenue. … [Read more...] about An interview with Mark Thierer, President of SXC Health
Mississauga's Nuvo Research, which has developed an osteoarthritis pain-killing cream that is absorbed through the skin, saw its revenues leap on a … [Read more...] about Breaking down the balance sheet of Nuvo Research (TSX:NRI)
"Story" stocks. Sometimes, as investors, we ignore the numbers and dive headlong into a brilliant pitch. Unfortunately, many stories are later … [Read more...] about 5 Questions with Donald McCaffrey, President of Resverlogix
Founded in 2003, Toronto based Bioexx Specialty Proteins is in the business of oilseed processing. The Company opened its first facility in Saskatoon … [Read more...] about A look at the balance sheet of Bioexx Specialty Proteins (TSX:BXI)